Thermo Fisher buys One Lambda for $925mm in cash
Thermo Fisher Scientific Inc. will pay $925mm in cash to acquire privately held transplant diagnostics firm One Lambda Inc. The price, which amounts to over five times the acquired company’s 2011 revenues, includes the cost of a three-year retention program for key One Lambda employees, payments to shareholders for noncompete agreements, and a one-year earn-out provision based on financial achievements.
- In Vitro Diagnostics
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Antisense, Oligonucleotides
- Full Acquisition
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.